Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cardinal Health (DE:CLH)
FRANKFURT:CLH
Cardinal Health (CLH) Stock Price & Analysis
1 Followers
CLH Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€71.58 - €105.82
Previous Close€95.76
Volume0.00
Average Volume (3M)119.00
Market Cap
€23.46B
Enterprise Value€23.64B
Total Cash (Recent Filing)$4.59B
Total Debt (Recent Filing)$4.72B
Price to Earnings (P/E)N/A
Beta0.18
Next Earnings
May 02, 2024EPS Estimate
€1.83Last Dividend Ex-Date
Mar 28, 2024Dividend Yield1.95%
Share Statistics
EPS (TTM)N/A
Shares Outstanding243,233,153
10 Day Avg. Volume7
30 Day Avg. Volume119
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-2.84
Price to Sales (P/S)0.11
Price to Cash Flow (P/CF)5.30
P/FCF Ratio5.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.11
Enterprise Value/Gross Profit0.12
Enterprise Value/Ebitda68.91
Forecast
1Y Price Target
€107.80Price Target Upside12.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
Cardinal Health News
PremiumCompany Announcements
Cardinal Health Executives Discuss Quarterly Results and Future Projections
PremiumCompany Announcements
Cardinal Health Announces New Business Structure and SegmentsBulls Say, Bears Say
Bulls Say
Financial PerformanceAnalyst reiterates an Outperform rating and $118 price target for CAH, reflecting confidence in the company's ability to maintain robust profit and cash flow growth.
Growth StrategyThe company's plan to leverage new customer wins, specialty growth, and strategic actions to offset revenue loss showcases its proactive approach to driving growth.
ResilienceCardinal Health's reaffirmed adjusted EPS guidance and long-term profit growth targets signal the company's resilience and adaptability to market changes.
Bears Say
Competitive RiskIncreasing focus on the risk of rising competitive intensity following Optum’s move to a competitor could impact market sentiment.
Contract LossLoss of the OptumRx contract, which represented a significant portion of Cardinal's total revenue, may impact financial performance.
Earnings RevisionAnalyst revises downward the EPS estimates for FY25 and FY26 due to the OptumRx contract loss.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
4.05% Other Institutional Investors
95.95% Public Companies and
Individual Investors
CLH FAQ
What was Cardinal Health’s price range in the past 12 months?
Cardinal Health lowest stock price was €71.58 and its highest was €105.82 in the past 12 months.
What is Cardinal Health’s market cap?
Currently, no data Available
When is Cardinal Health’s upcoming earnings report date?
Cardinal Health’s upcoming earnings report date is May 02, 2024 which is today.
How were Cardinal Health’s earnings last quarter?
Cardinal Health released its earnings results on Feb 01, 2024. The company reported €1.707 earnings per share for the quarter, beating the consensus estimate of €1.498 by €0.209.
Is Cardinal Health overvalued?
According to Wall Street analysts Cardinal Health’s price is currently Undervalued.
Does Cardinal Health pay dividends?
Cardinal Health pays a Quarterly dividend of €0.47 which represents an annual dividend yield of 1.95%. See more information on Cardinal Health dividends here
What is Cardinal Health’s EPS estimate?
Cardinal Health’s EPS estimate is €1.83.
How many shares outstanding does Cardinal Health have?
Currently, no data Available
What happened to Cardinal Health’s price movement after its last earnings report?
Cardinal Health reported an EPS of €1.707 in its last earnings report, beating expectations of €1.498. Following the earnings report the stock price went up 2.532%.
Which hedge fund is a major shareholder of Cardinal Health?
Among the largest hedge funds holding Cardinal Health’s share is Elliott Investment Management LP. It holds Cardinal Health’s shares valued at 202M.
---
Cardinal Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€107.80 (12.57% Upside)
€107.80 (12.57% Upside)
Blogger Sentiment
Bullish
DE:CLH Sentiment 88%
Sector Average 70%
Sector Average 70%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.11%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
4.70%
Trailing 12-Months
Company Description
Cardinal Health
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The company operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.
---
CLH Company Deck
---
CLH Earnings Call
Q2 2024
0:00 / 0:00
---
CLH Revenue Breakdown
92.68% Pharmaceutical
7.32% Medical
---
CLH Stock 12 Months Forecast
Average Price Target
€107.80
▲(12.57% Upside)
Technical Analysis
Cardinal Health
―
McKesson
―
CVS Health
―
Walgreens Boots Alliance
―
Gilead Sciences
―
Best Analysts Covering CLH
1 Year
1 Year Success Rate
9/11 ratings generated profit
1 Year Average Return
+20.22%
reiterated a buy rating 3 months ago
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +20.22% per trade.
---